Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
Sponsor: Alphatec Spine, Inc.
Terminated
Product no longer on the market
Other terminated trials from Alphatec Spine, Inc.
- Lumbar Degenerative Disc Disease · Phase NA · Nov 2013
- Cervical Degenerative Disc Disease · Aug 2013
- Vertebral Compression Fractures · Phase NA · Jul 2013
More terminations from Alphatec Spine, Inc.
Other Lumbar Degenerative Disc Disease trials with similar outcome
This observational or N/A phase trial investigates Lumbar Degenerative Disc Disease and is currently terminated or withdrawn. Alphatec Spine, Inc. leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alphatec Spine, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .